339 completed. 339 Phase 1, 97 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 339 | Completed 339 |
| Phase 2 | 97 | Completed 97 |
Follow Anemia: new trials by email Literature Review of Anemia trials Research Report on Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of an Oral Nutritional Supplement on the Nutritional and Health Outcomes of the Elderly Oral nutritional supplementation - Hypertension, Hand Grip Strength | Phase 1 | Completed | University of Ghana | 81 | 2025-11-24 | 2026-04-21 |
| Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects HRS-5965 Capsules, Clopidogrel, Clarithromycin - Complement Mediated Glomerular Diseases, Hemolytic Anemia | Phase 1 | Completed | Chengdu Suncadia Medicine Co., Ltd. | 36 | 2025-07-08 | 2025-08-20 |
| A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy Subjects HRS-5965 Capsules - IgA Nephropathy, Paroxysmal Nocturnal Hemoglobinuria | Phase 1 | Completed | Chengdu Suncadia Medicine Co., Ltd. | 16 | 2025-06-30 | 2025-08-20 |
| A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants Etavopivat, Moxifloxacin, Placebo - Healthy Volunteers, Sickle Cell Disease | Phase 1 | Completed | Novo Nordisk A/S | 33 | 2025-06-09 | 2026-01-02 |
| EFFICACY OF IV VERSUS ORAL IRON IN THE TREATMENT OF IRON DEFICIENCY ANEMIA DURING PREGNANCY Iron Carboxymaltose, Iron Polymaltose Complex - Iron Deficiency Anaemia in Childbirth | Phase 1 | Completed | Dr Salaha Azam | 112 | 2025-06-01 | 2026-02-03 |
| A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants Etavopivat, Digoxin, Pitavastatin - Healthy Volunteers Sickle Cell Disease, Thalassemia | Phase 1 | Completed | Novo Nordisk A/S | 37 | 2025-02-06 | 2026-09-29 |
| A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia YTS109 cell - Autoimmune Hemolytic Anemia | Phase 1 | Completed | China Immunotech (Beijing) Biotechnology Co., Ltd. | 7 | 2025-01-15 | 2026-03-02 |
| A Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Study, and QT Interval Study of HRS-5965 Capsules in Healthy Subjects HRS-5965 capsule, HRS-5965 capsule placebo - Hemolytic Anemia | Phase 1 | Completed | Chengdu Suncadia Medicine Co., Ltd. | 32 | 2024-11-09 | 2025-07-04 |
| Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects Carbon-14 labeled HSK39297 - Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 1 | Completed | Haisco Pharmaceutical Group Co., Ltd. | 7 | 2024-09-09 | 2025-02-28 |
| A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants Etavopivat - Healthy Volunteers, Sickle Cell Disease | Phase 1 | Completed | Novo Nordisk A/S | 24 | 2024-08-26 | 2025-12-29 |
| A Research Study of the Effect of Food on Etavopivat in Healthy Participants Etavopivat - Healthy Volunteers Sickle Cell Disease, Thalassemia | Phase 1 | Completed | Novo Nordisk A/S | 16 | 2024-05-28 | 2025-10-10 |
| A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major CS-101 injection - Beta-Thalassemia Major | Phase 1 | Completed | CorrectSequence Therapeutics Co., Ltd | 9 | 2024-04-18 | 2026-02-10 |
| A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants LP-005 Dose 1 (Single), LP-005 Dose 2 (Single), LP-005 Dose 3 (Single) - Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 1 | Completed | Longbio Pharma | 68 | 2023-11-23 | 2025-12-15 |
| Dose Escalation of BCX10013 in Participants with Paroxysmal Nocturnal Hemoglobinuria (PNH) BCX10013 - Paroxysmal Nocturnal Hemoglobinuria | Phase 1 | Completed | BioCryst Pharmaceuticals | 8 | 2023-10-24 | 2025-01-08 |
| Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia Ferric Carboxymaltose Injection, Ferric Carboxymaltose Injection [Ferinject] - Iron Deficiency, Anaemia | Phase 1 | Completed | Sichuan Huiyu Pharmaceutical Co., Ltd | 84 | 2023-10-09 | 2024-04-18 |
| Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia Bitopertin - Steroid-refractory Diamond-Blackfan Anemia (DBA) | Phase 1 / Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 15 | 2023-07-25 | 2026-06-30 |
| Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD) Motixafortide, Natalizumab, Leukapheresis - Sickle Cell Disease | Phase 1 | Completed | Washington University School of Medicine | 10 | 2023-07-07 | 2025-08-11 |
| An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY-4) Povetacicept - Idiopathic Thrombocytopenic Purpura, Immune Thrombocytopenia | Phase 1 / Phase 2 | Completed | Alpine Immune Sciences Inc, A Subsidiary of Vertex | 30 | 2023-07-03 | 2026-09-14 |
| Oral Ketamine for Treatment of Vaso-Occlusive Pain Ketamine Hydrochloride - Vaso-occlusive Crisis | Phase 1 | Completed | Boston Children's Hospital | 10 | 2023-05-26 | 2026-09-28 |
| Hydroxyurea and EPO in Sickle Cell Disease Hydroxyurea, Epoetin Alfa-BioSimilar - Anemia, Sickle Cell, Sickle Cell Disease | Phase 1 / Phase 2 | Completed | Julia Xu | 17 | 2023-05-25 | 2026-01-07 |
Showing 20 of 339. Sign in to see all of them.
Anemia, Sickle Cell (91) · Anemia, Refractory, with Excess of Blasts (66) · Leukemia, Myeloid, Acute (51) · Myelodysplastic Syndromes (45) · Leukemia, Myelomonocytic, Chronic (42) · Leukemia (39) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (38) · Anemia, Aplastic (25) · Congenital Abnormalities (25) · Leukemia, Lymphocytic, Chronic, B-Cell (25) · Blast Crisis (24) · Myeloproliferative Disorders (24) · Anemia, Iron-Deficiency (21) · Anemia, Refractory (19)
Hemic and Lymphatic Diseases (339) · Hematologic Diseases (331) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (158) · Anemia, Hemolytic (135) · Bone Marrow Diseases (132) · Genetic Diseases, Inborn (128) · Anemia, Hemolytic, Congenital (113) · Hemoglobinopathies (107) · Pathological Conditions, Signs and Symptoms (106) · Pathologic Processes (99) · Disease Attributes (89) · Neoplasms (85) · Chronic Disease (81) · Neoplasms by Histologic Type (80)
fludarabine phosphate (23) · Cyclosporine (18) · Cyclophosphamide (16) · Peripheral Blood Stem Cell Transplantation (15) · Mycophenolic Acid (14) · fludarabine (14) · Whole-Body Irradiation (13) · Filgrastim (11) · Hydroxyurea (10) · GSK1278863 (9) · Antilymphocyte Serum (8) · Cytarabine (8) · Tacrolimus (7) · plerixafor (7) · Granulocyte Colony-Stimulating Factor (6)
National Heart, Lung, and Blood Institute (NHLBI) (18) · National Cancer Institute (NCI) (15) · Fred Hutchinson Cancer Center (13) · GlaxoSmithKline (13) · Baylor College of Medicine (7) · Memorial Sloan Kettering Cancer Center (6) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (6) · M.D. Anderson Cancer Center (5) · Novo Nordisk A/S (5) · Pfizer (5) · Akebia Therapeutics (4) · Case Comprehensive Cancer Center (4) · Children's Hospital Medical Center, Cincinnati (4) · Duke University (4) · Eli Lilly and Company (4)
United States (234) · United Kingdom (24) · China (16) · Germany (10) · Australia (9) · France (9) · Italy (9) · Spain (8) · Brazil (6) · Canada (6) · Japan (6) · Netherlands (5) · South Africa (5) · South Korea (5) · Thailand (5)
John F Tisdale, M.D. (7) · Brenda Sandmaier (4) · Carla Washington, PhD (3) · David Diemert, MD (3) · Francis Giles (3) · Joanne Kurtzberg, MD (3) · Jorge Cortes (3) · Jorge Cortes, MD (3)
PMID 24916507, PMID 26589907, PMID 28464026, PMID 29669226, PMID 30957581, PMID 32499241, PMID 34175041, PMID 36005278, PMID 40891510, PMID 12114413, PMID 12957457, PMID 15570084, PMID 16278404, PMID 17536019, PMID 17620452, PMID 17640728, PMID 18299450, PMID 18439858, PMID 19179301, PMID 19208097, PMID 19786617, PMID 20071660, PMID 20858843, PMID 20876669, PMID 21149673, PMID 21403127, PMID 21477202, PMID 21742281, PMID 22009536, PMID 22055111, PMID 22154022, PMID 22430088, PMID 22546497, PMID 22887019, PMID 22915641, PMID 23131255, PMID 23377438, PMID 23416852, PMID 23953882, PMID 24296492, PMID 24715706, PMID 24988449, PMID 25185712, PMID 25222041, PMID 25310303, PMID 25377872, PMID 25621498, PMID 25701866, PMID 25824692, PMID 25933833
P30CA015704 (6), U01CA062461 (6), 2014 (5), P30CA006973 (5), 2017 (3), 2023 (3), P01CA015396 (3), P01CA018029 (3), P01CA044991 (3), 2019 (2), P30CA016058 (2), P30CA016672 (2), R01CA067803 (2), R01HL081499 (2), U01CA070095 (2)